Literature DB >> 27956205

Early echocardiographic predictors of outcomes in the mouse transverse aortic constriction heart failure model.

Caryn Hampton1, Raymond Rosa1, Barry Campbell2, Richard Kennan2, Loise Gichuru3, Xiaoli Ping3, Xiaolan Shen3, Kersten Small4, Jeffrey Madwed4, Joseph J Lynch5.   

Abstract

INTRODUCTION: Mouse transverse aortic constriction (TAC) is a widely-used model of pressure overload-induced heart failure. An intrinsic limitation of the model is variability in the response to pressure overload even when employing a standard severity of stenosis. Few literature studies have explicitly reported the use of entry criteria or early predictors to mitigate variability and enrich outcomes in this model.
METHODS: Eleven-week-old male C57BL/6J mice underwent TAC or sham surgery. Left ventricular (LV) function and dimensions were assessed by M-mode echocardiography at baseline (pre) and 3, 9 and 12weeks post-procedure (end-study). At 24h post-procedure, transverse aortic flow velocities were obtained for estimating trans-TAC pressure gradients. Invasive LV hemodynamic assessments were performed and terminal heart and lung weights obtained at end-study.
RESULTS: TAC mice displayed early development of LV hypertrophy and wall thickening followed by the later development of LV chamber dilation, and progressive development of LV systolic and diastolic dysfunction. The use of a pre-defined trans-TAC pressure gradient criterion of 45-60mmHg did not affect end-study organ weight, echocardiographic and invasive hemodynamic outcomes. A post-hoc receiver operator characteristic (ROC) analysis identified early 3week echocardiographic measures of LVmass(echo) and ejection fraction, with threshold changes of ~+30% and -10% normalized to baseline respectively, as good predictors for multiple end-study organ weight, echocardiographic and invasive hemodynamic outcomes. DISCUSSION: This ROC analysis has identified early predictive threshold changes which may serve, alone or in combination, as entry criteria to enrich outcome in this model.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; Methods; Receiver operator characteristic (ROC) analysis; Trans-aortic pressure gradient; Transverse aortic constriction (TAC)

Mesh:

Year:  2016        PMID: 27956205     DOI: 10.1016/j.vascn.2016.12.001

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  6 in total

1.  FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt.

Authors:  Wei Shen; Hongqi Li; Hao Su; Kangyu Chen; Ji Yan
Journal:  Mol Cell Biochem       Date:  2021-02-06       Impact factor: 3.396

2.  Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.

Authors:  Jaime Ibarrola; Ernesto Martínez-Martínez; J Rafael Sádaba; Vanessa Arrieta; Amaia García-Peña; Virginia Álvarez; Amaya Fernández-Celis; Alicia Gainza; Patrick Rossignol; Victoria Cachofeiro Ramos; Natalia López-Andrés
Journal:  Int J Mol Sci       Date:  2017-07-31       Impact factor: 5.923

3.  Effects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model.

Authors:  Caryn Hampton; Raymond Rosa; Daphne Szeto; Gail Forrest; Barry Campbell; Richard Kennan; Shubing Wang; Chin-Hu Huang; Loise Gichuru; Xiaoli Ping; Xiaolan Shen; Kersten Small; Jeffrey Madwed; Joseph J Lynch
Journal:  SAGE Open Med       Date:  2017-03-30

4.  Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1.

Authors:  Lara Matilla; Vanessa Arrieta; Eva Jover; Amaia Garcia-Peña; Ernesto Martinez-Martinez; Rafael Sadaba; Virginia Alvarez; Adela Navarro; Amaya Fernandez-Celis; Alicia Gainza; Enrique Santamaria; Joaquín Fernandez-Irigoyen; Patrick Rossignol; Faiez Zannad; Natalia Lopez-Andres
Journal:  Cells       Date:  2020-07-10       Impact factor: 6.600

Review 5.  Experimental models of cardiac physiology and pathology.

Authors:  Jae Gyun Oh; Changwon Kho; Roger J Hajjar; Kiyotake Ishikawa
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

6.  The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.

Authors:  Coenraad Withaar; Laura M G Meems; George Markousis-Mavrogenis; Cornelis J Boogerd; Herman H W Silljé; Elisabeth M Schouten; Martin M Dokter; Adriaan A Voors; B Daan Westenbrink; Carolyn S P Lam; Rudolf A de Boer
Journal:  Cardiovasc Res       Date:  2021-07-27       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.